LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 229 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $8,573,000 | -4.1% | 99,562 | -0.7% | 3.85% | -7.4% |
| Q2 2022 | $8,944,000 | +7.9% | 100,244 | +36.0% | 4.16% | +21.0% |
| Q1 2022 | $8,291,000 | -74.4% | 73,700 | -77.4% | 3.44% | -86.1% |
| Q4 2020 | $32,431,000 | +5.8% | 326,100 | +1.4% | 24.83% | -22.1% |
| Q3 2020 | $30,645,000 | +196.5% | 321,500 | +247.9% | 31.88% | +59.2% |
| Q2 2020 | $10,336,000 | -11.7% | 92,407 | -42.6% | 20.02% | +61.8% |
| Q1 2020 | $11,702,000 | +292.3% | 160,919 | +437.0% | 12.38% | +327.5% |
| Q3 2019 | $2,983,000 | -84.4% | 29,965 | -82.1% | 2.90% | -78.0% |
| Q2 2019 | $19,119,000 | +1.4% | 167,487 | +11.7% | 13.16% | +21.4% |
| Q1 2019 | $18,857,000 | – | 150,000 | – | 10.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |